5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Pediatric Cardiac Rehabilitation
Pediatric Cardiac Rehabilitation is a specialized program designed to support children with heart conditions in their recovery and overall well-being. Tailored to meet the unique needs of young patients, this comprehensive rehabilitation approach focuses on improving cardiovascular health, enhancing physical fitness, and fostering emotional well-being. The program typically includes a combination of supervised exercise sessions, educational components for both children and their families, and psychosocial support. By addressing the physical and emotional aspects of cardiac health, Pediatric Cardiac Rehabilitation aims to optimize the quality of life for children with heart conditions, promoting long-term cardiovascular health and resilience.
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas J Webster
Brown University, United States
Federico Benetti
Benetti Foundation, Argentina
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Syed Raza
Awali Hospital, BahrainSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain